NACL Industries Rights Issue Funds Utilization Confirmed
Rights Issue Funds Used As Planned
NACL Industries has confirmed no deviation in how it used its ₹249.29 crore rights issue funds during the quarter ending March 31, 2026. Crisil Ratings verified that the company's spending matched its earlier disclosures. As of this reporting period, ₹218.49 crore of the total funds raised has been utilized.
Main Fund Uses
The funds were primarily allocated to repay borrowings and to invest in its wholly-owned subsidiary, NACL Spec-Chem Limited, which plays a key role in the group's strategic expansion plans.
Delay in GCP Spending Noted
However, the company's filing highlighted a slight delay in spending allocated for General Corporate Purposes (GCP). As of March 31, 2026, ₹29.91 crore was used for GCP, falling short of the ₹45.53 crore initially estimated in the prospectus. This suggests a delay in the planned schedule for these purposes.
Investor Reassurance
For shareholders, this update offers reassurance that NACL Industries is managing its finances responsibly, channeling raised capital into debt reduction and strategic investments as promised. The remaining unutilized funds provide flexibility for future strategic initiatives.
Rights Issue Background
NACL Industries conducted a rights issue that successfully raised ₹249.29 crore. The main objectives for this fundraising were to reduce outstanding borrowings, inject capital into its wholly-owned subsidiary NACL Spec-Chem Limited, and for general corporate purposes.
Key Figures
Key Figures for Rights Issue Funds (as of March 31, 2026):
- Total raised: ₹249.29 crore
- Total utilized: ₹218.49 crore
- Unutilized: ₹30.80 crore
- Used for debt repayment: ₹104.00 crore
- Invested in NACL Spec-Chem: ₹83.00 crore
- Used for General Corporate Purposes (GCP): ₹29.91 crore (Prospectus estimate: ₹45.53 crore)
What to Watch Next
Investors will watch for plans and timelines regarding the utilization of the remaining ₹30.80 crore, especially for General Corporate Purposes. Updates on NACL Spec-Chem Limited's performance, funded by these proceeds, will also be of interest.
